Acadia Healthcare (NASDAQ:ACHC) Hits New 1-Year Low on Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price hit a new 52-week low during mid-day trading on Friday after StockNews.com downgraded the stock from a hold rating to a sell rating. The company traded as low as $65.67 and last traded at $66.72, with a volume of 148079 shares changing hands. The stock had previously closed at $66.73.

ACHC has been the subject of a number of other research reports. Barclays decreased their target price on shares of Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a research note on Thursday. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, March 5th. Mizuho reduced their price objective on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating for the company in a research note on Friday. TD Cowen lifted their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a research note on Friday, March 1st. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a research note on Monday, March 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $88.89.

Insider Buying and Selling

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ACHC. Fifth Third Bancorp increased its holdings in shares of Acadia Healthcare by 25.5% during the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the period. Estate Counselors LLC boosted its position in Acadia Healthcare by 0.9% in the third quarter. Estate Counselors LLC now owns 16,410 shares of the company’s stock valued at $1,154,000 after buying an additional 145 shares in the last quarter. Tranquility Partners LLC boosted its position in Acadia Healthcare by 5.3% in the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock valued at $264,000 after buying an additional 170 shares in the last quarter. Mackenzie Financial Corp lifted its position in shares of Acadia Healthcare by 1.3% during the third quarter. Mackenzie Financial Corp now owns 15,737 shares of the company’s stock worth $1,063,000 after purchasing an additional 199 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its position in shares of Acadia Healthcare by 0.3% during the first quarter. New York State Teachers Retirement System now owns 76,054 shares of the company’s stock worth $6,025,000 after purchasing an additional 200 shares in the last quarter.

Acadia Healthcare Price Performance

The stock’s 50-day moving average price is $76.77 and its 200-day moving average price is $77.52. The company has a market capitalization of $6.11 billion, a price-to-earnings ratio of -472.25, a price-to-earnings-growth ratio of 1.97 and a beta of 1.31. The company has a quick ratio of 0.67, a current ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. During the same period in the prior year, the business earned $0.75 earnings per share. Acadia Healthcare’s quarterly revenue was up 9.1% on a year-over-year basis. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.56 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.